xuesen dong
University of British Columbia
Vancouver, Canada
Associate Editor
Cancer Molecular Targets and Therapeutics
Editors
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial board
Type at least 3 characters
Shape the future of research in your field
Join the board
Associate Editors
patrycja dubielecka
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
massimo fantini
Precision Biologics, Inc.
Rockville, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
piero ferolla
Mutidisciplinary NET Group, Umbria Regional Cancer Network
Perugia, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
isacco ferrarini
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
elisabetta ferretti
Department of Experimental Medicine, Faculty of Medicine and Dentistry, Sapienza University of Rome
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
soldano ferrone
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
niklas finnberg
Medivir (Sweden)
Huddinge, Sweden
Associate Editor
Cancer Molecular Targets and Therapeutics
liwu fu
Sun Yat-sen University Cancer Center (SYSUCC)
Guangzhou, China
Associate Editor
Cancer Molecular Targets and Therapeutics
tomofusa fukuyama
Department of Hematology, International University of Health and Welfare Hospital
Tochigi, Japan
Associate Editor
Cancer Molecular Targets and Therapeutics
laura gatti
IRCCS Carlo Besta Neurological Institute Foundation
Milan, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
shanmugasundaram ganapathy-kanniappan
School of Medicine, University of Maryland
Baltimore, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
tomas garzon-muvdi
Jefferson University Hospitals, Thomas Jefferson University
Philadelphia, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
navnath s gavande
Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University
Detroit, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
ilias georgakopoulos-soares
University of Texas at Austin School of Nursing
Austin, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
silvia giordano
University of Turin
Turin, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics